Therapeutic Targeting of the Cancer-Specific Cell Surface Biomarker nfP2X₇

Julian A Barden^1*, Angus Gidley-Baird¹, Liew Cheng Teh¹, G-Halli Rajasekariah¹, John Pedersen², Neil I Christensen³, Derek Spielman⁴ and David M Ashley⁵

¹Biosceptre (Aust) Pty Ltd, Riverside Life Sciences, 11 Julius Ave, North Ryde, N.S.W. 2113, Australia, E-mail: research.support@sydney.edu.au

²TissuPath, 165 Burwood Rd, Hawthorn, Vic 3122, Australia, E-mail: research.support@sydney.edu.au

³School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA, E-mail: research.support@sydney.edu.au

⁴Department of Veterinary Pathology, The University of Sydney, N.S.W. 2006, Australia, E-mail: research.support@sydney.edu.au

⁵Deakin University, School of Medicine, Geelong, Vic. 3217, Australia, E-mail: research.support@sydney.edu.au

^*Corresponding Author: Julian A Barden, Biosceptre (Aust) Pty Ltd, Riverside Life Sciences, 11 Julius Ave, North Ryde, N.S.W. 2113, Australia, Tel: 124908280 Email: